Dec 02, 2024
2024 Judicial Review: Significant Court Decisions on Medical Liability Issues
Between fall 2023 and summer 2024, state supreme courts handed down mixed decisions on medical liability issues affecting healthcare professionals.
From
The Doctor’s Advocate
Search
October 01, 2024, Healthcare Risk Management
Respond Carefully to Notice of Intent
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, shares suggestions for how to properly respond to patients who communicate their intent to sue.
The California Medical Association Selects The Doctors Company as Its Exclusive Medical Professional Liability Insurance Company Corporate Sponsor
The California Medical Association (CMA), representing nearly 50,000 physicians, has chosen The Doctors Company, part of TDC Group, as its exclusive medical professional liability insurance company (MPLI) corporate sponsor.
Dec 02, 2024
Industry and Company News Fourth Quarter 2024
Announcements in the fourth quarter 2024 include affirmation of our ratings by AM Best and Fitch Ratings.
From
The Doctor’s Advocate
The Doctors Company Commits to Health Workforce Well-Being as a Founding Member of the National Academy of Medicine’s Change Maker Campaign
On the 1st anniversary of the National Plan for Health Workforce Well-Being, The Doctors Company reinforces its commitment to health workforce well-being as a founding member of the Change Maker campaign of the National Academy of Medicine (NAM). The national plan provides a roadmap for collective action to address the health worker burnout crisis, strengthen workplace well-being, and restore the nation’s health.
Professional Education
Module 3: Safe Prescribing of Opioids and CNS Depressants (Innovations and Smart Approaches in Safe Prescribing)
Learn several new concepts and innovation tips. Learn about the new CDC Guidelines about pain. This program will show how to treat pain, opioid withdrawal, and/or opioid addiction. It will show how to taper opioids and you will learn how to conduct “motivational interviewing.” You will examine multimodal approaches for chronic pain, including physical, psych-behavioral, procedural, and pharmacological modalities. You will be encouraged to use tools for prescribing and tapering opioids and benzodiazepines. You will be provided with an overview of the use of CURES 2.0. Lastly, the program will examine how to best screen patients for use of CNS depressants and marijuana to mitigate the potential for contraindications with opioids. This module consists of seven audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
April 03, 2025, Cardiology Magazine
Critical Insights: Lessons From Delayed Diagnosis, Treatment in the ED
John P. Erwin III, MD, MBA, MACC, Chair, Department of Internal Medicine, Prisma Health Upstate; Clinical Professor, School of Medicine Greenville, University of South Carolina; and Debra A. Davidson, MJ, CPHRM, CPPS, Senior Patient Safety Risk Manager, The Doctors Company, part of TDC Group, review how care and treatment delays contribute to poor patient outcomes and medical malpractice litigation.
Artificial Intelligence, COVID-19, and the Future of Pandemics
Artificial intelligence (AI) has proven of value in the COVID-19 pandemic and shows promise for mitigating future healthcare crises.
Shoulder Dystocia Documentation: Implementing a Protocol
Shoulder dystocia claims have traditionally been among the most problematic to defend.
MPL Case: Could Closing the Loop Have Saved This Patient's Life?
Confirming a colleague’s receipt and understanding of serious findings is part of patient safety. Further, closed-loop communication expresses mutual respect, which contributes to professional satisfaction.